Atlas Trials

Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery

Clinical trial NCT02267226 · COMPLETED

Trial details

NCT number
NCT02267226
Sponsor
Octapharma
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Congenital Fibrinogen Deficiency
Start date
2014-09-01
Primary completion
2018-02-14
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.